Cargando…
Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631549/ https://www.ncbi.nlm.nih.gov/pubmed/35271707 http://dx.doi.org/10.1182/bloodadvances.2021006922 |
_version_ | 1784823836327280640 |
---|---|
author | Iacoboni, Gloria Rejeski, Kai Villacampa, Guillermo van Doesum, Jaap A. Chiappella, Annalisa Bonifazi, Francesca Lopez-Corral, Lucia van Aalderen, Michiel Kwon, Mi Martínez-Cibrian, Nuria Bramanti, Stefania Reguera-Ortega, Juan Luis Camacho-Arteaga, Lina Schmidt, Christian Marín-Niebla, Ana Kersten, Marie José Martin Garcia-Sancho, Alejandro Zinzani, Pier Luigi Corradini, Paolo van Meerten, Tom Subklewe, Marion Barba, Pere |
author_facet | Iacoboni, Gloria Rejeski, Kai Villacampa, Guillermo van Doesum, Jaap A. Chiappella, Annalisa Bonifazi, Francesca Lopez-Corral, Lucia van Aalderen, Michiel Kwon, Mi Martínez-Cibrian, Nuria Bramanti, Stefania Reguera-Ortega, Juan Luis Camacho-Arteaga, Lina Schmidt, Christian Marín-Niebla, Ana Kersten, Marie José Martin Garcia-Sancho, Alejandro Zinzani, Pier Luigi Corradini, Paolo van Meerten, Tom Subklewe, Marion Barba, Pere |
author_sort | Iacoboni, Gloria |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9631549 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Society of Hematology |
record_format | MEDLINE/PubMed |
spelling | pubmed-96315492022-11-04 Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma Iacoboni, Gloria Rejeski, Kai Villacampa, Guillermo van Doesum, Jaap A. Chiappella, Annalisa Bonifazi, Francesca Lopez-Corral, Lucia van Aalderen, Michiel Kwon, Mi Martínez-Cibrian, Nuria Bramanti, Stefania Reguera-Ortega, Juan Luis Camacho-Arteaga, Lina Schmidt, Christian Marín-Niebla, Ana Kersten, Marie José Martin Garcia-Sancho, Alejandro Zinzani, Pier Luigi Corradini, Paolo van Meerten, Tom Subklewe, Marion Barba, Pere Blood Adv Research Letter American Society of Hematology 2022-06-20 /pmc/articles/PMC9631549/ /pubmed/35271707 http://dx.doi.org/10.1182/bloodadvances.2021006922 Text en © 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. |
spellingShingle | Research Letter Iacoboni, Gloria Rejeski, Kai Villacampa, Guillermo van Doesum, Jaap A. Chiappella, Annalisa Bonifazi, Francesca Lopez-Corral, Lucia van Aalderen, Michiel Kwon, Mi Martínez-Cibrian, Nuria Bramanti, Stefania Reguera-Ortega, Juan Luis Camacho-Arteaga, Lina Schmidt, Christian Marín-Niebla, Ana Kersten, Marie José Martin Garcia-Sancho, Alejandro Zinzani, Pier Luigi Corradini, Paolo van Meerten, Tom Subklewe, Marion Barba, Pere Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma |
title | Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma |
title_full | Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma |
title_fullStr | Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma |
title_full_unstemmed | Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma |
title_short | Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma |
title_sort | real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma |
topic | Research Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631549/ https://www.ncbi.nlm.nih.gov/pubmed/35271707 http://dx.doi.org/10.1182/bloodadvances.2021006922 |
work_keys_str_mv | AT iacobonigloria realworldevidenceofbrexucabtageneautoleucelforthetreatmentofrelapsedorrefractorymantlecelllymphoma AT rejeskikai realworldevidenceofbrexucabtageneautoleucelforthetreatmentofrelapsedorrefractorymantlecelllymphoma AT villacampaguillermo realworldevidenceofbrexucabtageneautoleucelforthetreatmentofrelapsedorrefractorymantlecelllymphoma AT vandoesumjaapa realworldevidenceofbrexucabtageneautoleucelforthetreatmentofrelapsedorrefractorymantlecelllymphoma AT chiappellaannalisa realworldevidenceofbrexucabtageneautoleucelforthetreatmentofrelapsedorrefractorymantlecelllymphoma AT bonifazifrancesca realworldevidenceofbrexucabtageneautoleucelforthetreatmentofrelapsedorrefractorymantlecelllymphoma AT lopezcorrallucia realworldevidenceofbrexucabtageneautoleucelforthetreatmentofrelapsedorrefractorymantlecelllymphoma AT vanaalderenmichiel realworldevidenceofbrexucabtageneautoleucelforthetreatmentofrelapsedorrefractorymantlecelllymphoma AT kwonmi realworldevidenceofbrexucabtageneautoleucelforthetreatmentofrelapsedorrefractorymantlecelllymphoma AT martinezcibriannuria realworldevidenceofbrexucabtageneautoleucelforthetreatmentofrelapsedorrefractorymantlecelllymphoma AT bramantistefania realworldevidenceofbrexucabtageneautoleucelforthetreatmentofrelapsedorrefractorymantlecelllymphoma AT regueraortegajuanluis realworldevidenceofbrexucabtageneautoleucelforthetreatmentofrelapsedorrefractorymantlecelllymphoma AT camachoarteagalina realworldevidenceofbrexucabtageneautoleucelforthetreatmentofrelapsedorrefractorymantlecelllymphoma AT schmidtchristian realworldevidenceofbrexucabtageneautoleucelforthetreatmentofrelapsedorrefractorymantlecelllymphoma AT marinnieblaana realworldevidenceofbrexucabtageneautoleucelforthetreatmentofrelapsedorrefractorymantlecelllymphoma AT kerstenmariejose realworldevidenceofbrexucabtageneautoleucelforthetreatmentofrelapsedorrefractorymantlecelllymphoma AT martingarciasanchoalejandro realworldevidenceofbrexucabtageneautoleucelforthetreatmentofrelapsedorrefractorymantlecelllymphoma AT zinzanipierluigi realworldevidenceofbrexucabtageneautoleucelforthetreatmentofrelapsedorrefractorymantlecelllymphoma AT corradinipaolo realworldevidenceofbrexucabtageneautoleucelforthetreatmentofrelapsedorrefractorymantlecelllymphoma AT vanmeertentom realworldevidenceofbrexucabtageneautoleucelforthetreatmentofrelapsedorrefractorymantlecelllymphoma AT subklewemarion realworldevidenceofbrexucabtageneautoleucelforthetreatmentofrelapsedorrefractorymantlecelllymphoma AT barbapere realworldevidenceofbrexucabtageneautoleucelforthetreatmentofrelapsedorrefractorymantlecelllymphoma |